{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T00:18:32Z","timestamp":1773101912103,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T00:00:00Z","timestamp":1704931200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T00:00:00Z","timestamp":1704931200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Retin Vitr"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>To compare the choroidal thickness and vascular profile of premature infants with ROP (retinopathy of prematurity) using a handheld SD-OCT device.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We performed horizontal SD-OCT scans through the fovea in 115 eyes of 66 premature infants. Premature infants included 2 groups [infants with ROP requiring treatment (as treatment group) vs. infants without ROP or with ROP not- requiring treatment (as no-treatment group)] Choroidal thicknesses (CT) were measured at 5 points, including the fovea, 250\u00a0\u00b5m, and 500\u00a0\u00b5m\u00a0mm nasal and temporal to the fovea. The choroidal vascularity index (CVI) and choroidal stromal index (CSI) were also calculated. The classification and regression tree (CRT) algorithm was used to predict the need for treatment based on all OCT characteristics.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Mean CT was higher in 500\u00a0\u00b5m nasal to the fovea compared to temporal CT (275.8\u2009\u00b1\u200964.8 and 257.1\u2009\u00b1\u200957.07, P value\u2009&lt;\u20090.03). No statistically significant difference was found regarding CVI, corrected CVI, and temporal and nasal CT in the treatment group versus the no-treatment group. The foveal CT was significantly lower in ROP patients with the plus disease compared to not-plus ROP (P value\u2009=\u20090.03. ANOVA, Bonferroni posthoc test). CT was not significantly different between plus and pre-plus patients (P-value\u2009=\u20090.9, ANOVA, Bonferroni posthoc test). No significant relationship was found between the stage of ROP and choroidal thickness (P value\u2009&gt;\u20090.05, GEE). The decision tree analysis showed that in infants with ROP, the most important predictor for the need for treatment is CSI.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>This study delineated the possible effectiveness of choroidal measurements as an additive to decision-making for ROP. We also demonstrated that choroidal involution is associated with the presence of plus disease, not with the stage of ROP. We demonstrated that choroidal measurements are very sensitive but not specific tools for assessing the need for treatment in ROP patients.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40942-023-00520-6","type":"journal-article","created":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T06:01:27Z","timestamp":1704952887000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Choroidal measurements in decision making for retinopathy of prematurity: a decision tree analysis"],"prefix":"10.1186","volume":"10","author":[{"given":"Mohammadreza Mehrabi","family":"Bahar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farhad","family":"Salari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Afsar","family":"Dastjanifarahani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fariba","family":"Ghassemi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"III","given":"C. Armitage","family":"Harper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9720-2028","authenticated-orcid":false,"given":"Fatemeh","family":"Bazvand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,1,11]]},"reference":[{"issue":"1","key":"520_CR1","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/pr.2013.205","volume":"74","author":"H Blencowe","year":"2013","unstructured":"Blencowe H, Lawn JE, Vazquez T, Fielder A, Gilbert C. Preterm-associated visual impairment and estimates of retinopathy of prematurity at regional and global levels for 2010. Pediatr Res. 2013;74(1):35\u201349.","journal-title":"Pediatr Res"},{"issue":"1","key":"520_CR2","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s40942-022-00364-6","volume":"8","author":"M Mirghorbani","year":"2022","unstructured":"Mirghorbani M, Rashidinia A, Yaseri M, Zarei M, Khojasteh H, Bazvand F, Modjtahedi BS. Progression of retinal vascularization after intravitreal anti-vascular-endothelial growth factor therapy in retinopathy of prematurity. Int J Retina Vitreous. 2022;8(1):13.","journal-title":"Int J Retina Vitreous"},{"key":"520_CR3","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s10456-007-9066-0","volume":"10","author":"J Chen","year":"2007","unstructured":"Chen J, Smith LE. Retinopathy of prematurity. Angiogenesis. 2007;10:133\u201340.","journal-title":"Angiogenesis"},{"issue":"1","key":"520_CR4","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.biocel.2009.10.006","volume":"42","author":"P Sapieha","year":"2010","unstructured":"Sapieha P, Hamel D, Shao Z, Rivera JC, Zaniolo K, Joyal JS, Chemtob S. Proliferative retinopathies: angiogenesis that blinds. Int J Biochem Cell Biol. 2010;42(1):5\u201312.","journal-title":"Int J Biochem Cell Biol"},{"key":"520_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40942-021-00340-6","volume":"7","author":"M Abrishami","year":"2021","unstructured":"Abrishami M, Boskabadi H, Abrishami M, Shekarchian F, Khadem-Rezaiyan M, Shoeibi N. Growth and neurodevelopmental status in patients with retinopathy of prematurity treated with intravitreal bevacizumab: a case\u2013control study. Int J Retina Vitreous. 2021;7:1\u20136.","journal-title":"Int J Retina Vitreous"},{"issue":"1","key":"520_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40942-020-00276-3","volume":"7","author":"F Bazvand","year":"2021","unstructured":"Bazvand F, Riazi-Esfahani H, Mirshahi A, Khodabande A, Khojastheh H, Farahani AD, Roohipourmoallai R, Imani M, Faghihi H, Adib NE, Bahar MM. Ocular complications following intravitreal bevacizumab injection for retinopathy of prematurity and assessment of risk factors. Int J Retina Vitreous. 2021;7(1):1\u20138.","journal-title":"Int J Retina Vitreous"},{"issue":"9","key":"520_CR7","doi-asserted-by":"publisher","first-page":"6238","DOI":"10.1167\/iovs.10-6742","volume":"52","author":"Z Shao","year":"2011","unstructured":"Shao Z, Dorfman AL, Seshadri S, Djavari M, Kermorvant-Duchemin E, Sennlaub F, Blais M, Polosa A, Varma DR, Joyal JS, Lachapelle P. Choroidal involution is a key component of oxygen-induced retinopathy. Invest Ophthalmol Vis Sci. 2011;52(9):6238\u201348.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"520_CR8","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s10633-005-2621-3","volume":"111","author":"AB Fulton","year":"2005","unstructured":"Fulton AB, Hansen RM, Moskowitz A, Barnaby AM. Multifocal ERG in subjects with a history of retinopathy of prematurity. Doc Ophthalmol. 2005;111:7\u201313.","journal-title":"Doc Ophthalmol"},{"issue":"6","key":"520_CR9","doi-asserted-by":"publisher","first-page":"E653","DOI":"10.1097\/OPX.0b013e3181a6a237","volume":"86","author":"AB Fulton","year":"2009","unstructured":"Fulton AB, Hansen RM, Moskowitz A. Development of rod function in term born and former preterm subjects. Optom Vis Sci. 2009;86(6):E653.","journal-title":"Optom Vis Sci"},{"key":"520_CR10","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s10633-009-9201-x","volume":"120","author":"E Kermorvant-Duchemin","year":"2010","unstructured":"Kermorvant-Duchemin E, Sapieha P, Sirinyan M, Beauchamp M, Checchin D, Hardy P, Sennlaub F, Lachapelle P, Chemtob S. Understanding ischemic retinopathies: emerging concepts from oxygen-induced retinopathy. Doc Ophthalmol. 2010;120:51\u201360.","journal-title":"Doc Ophthalmol"},{"issue":"6","key":"520_CR11","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.preteyeres.2009.06.003","volume":"28","author":"AB Fulton","year":"2009","unstructured":"Fulton AB, Hansen RM, Moskowitz A, Akula JD. The neurovascular retina in retinopathy of prematurity. Prog Retin Eye Res. 2009;28(6):452\u201382.","journal-title":"Prog Retin Eye Res"},{"issue":"6","key":"520_CR12","doi-asserted-by":"publisher","first-page":"4140","DOI":"10.1167\/iovs.12-11471","volume":"54","author":"TA Moreno","year":"2013","unstructured":"Moreno TA, O\u2019Connell RV, Chiu SJ, Farsiu S, Cabrera MT, Maldonado RS, Tran-Viet D, Freedman SF, Wallace DK, Toth CA. Choroid development and feasibility of choroidal imaging in the preterm and term infants utilizing SD-OCT. Invest Ophthalmol Vis Sci. 2013;54(6):4140\u20137.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"520_CR13","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1097\/IAE.0000000000000866","volume":"36","author":"MK Erol","year":"2016","unstructured":"Erol MK, Coban DT, Ozdemir O, Dogan B, Tunay ZO, Bulut M. Choroidal thickness in infants with retinopathy of prematurity. Retina. 2016;36(6):1191\u20138.","journal-title":"Retina"},{"issue":"2","key":"520_CR14","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1097\/IJG.0000000000001413","volume":"29","author":"MO Ulusoy","year":"2020","unstructured":"Ulusoy MO, Kivanc SA, Kal A. Evaluation of iridocorneal angle, choroidal thickness, and retinal nerve fiber layer thickness in children with a history of retinopathy of prematurity. J Glaucoma. 2020;29(2):112\u20136.","journal-title":"J Glaucoma"},{"issue":"11","key":"520_CR15","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1001\/jamaophthalmol.2013.5052","volume":"131","author":"WC Wu","year":"2013","unstructured":"Wu WC, Shih CP, Wang NK, Lien R, Chen YP, Chao AN, Chen KJ, Chen TL, Hwang YS, Lai CC, Huang CY. Choroidal thickness in patients with a history of retinopathy of prematurity. JAMA Ophthalmol. 2013;131(11):1451\u20138.","journal-title":"JAMA Ophthalmol"},{"issue":"4","key":"520_CR16","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1159\/000484631","volume":"60","author":"W Bowl","year":"2018","unstructured":"Bowl W, Bowl M, Schweinfurth S, Holve K, Andrassi-Darida M, Stieger K, Lorenz B. Choroidal thickness with swept-source optical coherence tomography versus foveal morphology in young children with a history of prematurity. Ophthalmic Res. 2018;60(4):205\u201313.","journal-title":"Ophthalmic Res"},{"issue":"1","key":"520_CR17","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s40942-023-00499-0","volume":"9","author":"F Bazvand","year":"2023","unstructured":"Bazvand F, Salari F, Barzi NH, Ghassemi F, Maleki A, Dastjani Farahani A, Imani Fooladi M, Taleghani NT, Shariati MK, Harper CA III, Mehrabi BM. Potential application of foveal structural measurements in treatment decision for retinopathy of prematurity: an OCT-based study. Int J Retina Vitreous. 2023;9(1):63.","journal-title":"Int J Retina Vitreous"},{"key":"520_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2021.101018","volume":"88","author":"AS Tsai","year":"2022","unstructured":"Tsai AS, Chou HD, Ling XC, Al-Khaled T, Valikodath N, Cole E, Yap VL, Chiang MF, Chan RP, Wu WC. Assessment and management of retinopathy of prematurity in the era of anti-vascular endothelial growth factor (VEGF). Prog Retin Eye Res. 2022;88: 101018.","journal-title":"Prog Retin Eye Res"},{"issue":"1","key":"520_CR19","doi-asserted-by":"publisher","first-page":"21090","DOI":"10.1038\/srep21090","volume":"6","author":"R Agrawal","year":"2016","unstructured":"Agrawal R, Gupta P, Tan KA, Cheung CM, Wong TY, Cheng CY. Choroidal vascularity index as a measure of vascular status of the choroid: measurements in healthy eyes from a population-based study. Sci Rep. 2016;6(1):21090.","journal-title":"Sci Rep"},{"key":"520_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-017-0943-1","volume":"14","author":"JC Rivera","year":"2017","unstructured":"Rivera JC, Holm M, Austeng D, Morken TS, Zhou T, Beaudry-Richard A, Sierra EM, Dammann O, Chemtob S. Retinopathy of prematurity: inflammation, choroidal degeneration, and novel promising therapeutic strategies. J Neuroinflamm. 2017;14:1\u20134.","journal-title":"J Neuroinflamm"},{"issue":"12","key":"520_CR21","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1038\/eye.2014.207","volume":"28","author":"MF Anderson","year":"2014","unstructured":"Anderson MF, Ramasamy B, Lythgoe DT, Clark D. Choroidal thickness in regressed retinopathy of prematurity. Eye. 2014;28(12):1461\u20138.","journal-title":"Eye"},{"issue":"11","key":"520_CR22","doi-asserted-by":"publisher","first-page":"7201","DOI":"10.1167\/iovs.12-10599","volume":"53","author":"KA Park","year":"2012","unstructured":"Park KA, Oh SY. Analysis of spectral-domain optical coherence tomography in preterm children: retinal layer thickness and choroidal thickness profiles. Invest Ophthalmol Vis Sci. 2012;53(11):7201\u20137.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"520_CR23","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.oret.2020.09.004","volume":"5","author":"S Mangalesh","year":"2021","unstructured":"Mangalesh S, McGeehan B, Tai V, Chen X, Tran-Viet D, Vajzovic L, Viehland C, Izatt JA, Cotten CM, Freedman SF, Maguire MG. Macular OCT characteristics at 36 weeks\u2019 postmenstrual age in infants examined for retinopathy of prematurity. Ophthalmol Retina. 2021;5(6):580\u201392.","journal-title":"Ophthalmol Retina"},{"issue":"3","key":"520_CR24","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1203\/00006450-199603000-00017","volume":"39","author":"P Hardy","year":"1996","unstructured":"Hardy P, Nuyt AM, Abran D, St-Louis J, Varma DR, Chemtob S. Nitric oxide in retinal and choroidal blood flow autoregulation in newborn pigs: interactions with prostaglandins. Pediatr Res. 1996;39(3):487\u201393.","journal-title":"Pediatr Res"},{"issue":"9","key":"520_CR25","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1167\/iovs.62.9.23","volume":"62","author":"Y He","year":"2021","unstructured":"He Y, Pettenkofer M, Nittala MG, Sadda SR, Tsui I, Chu A. Early postnatal oxygen exposure predicts choroidal thinning in neonates. Investig Ophthalmol Visual Sci. 2021;62(9):23.","journal-title":"Investig Ophthalmol Visual Sci"},{"issue":"2","key":"520_CR26","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1159\/000512620","volume":"65","author":"Y Islam","year":"2022","unstructured":"Islam Y, Andersen L, Agarwal-Sinha S. Angiographic review of choroidal involution in eyes with retinopathy of prematurity treated with bevacizumab. Ophthalmic Res. 2022;65(2):229\u201336.","journal-title":"Ophthalmic Res"},{"issue":"5","key":"520_CR27","doi-asserted-by":"publisher","first-page":"e611","DOI":"10.1111\/aos.14324","volume":"98","author":"A Lavric","year":"2020","unstructured":"Lavric A, TekavcicPompe M, Markelj S, Ding J, Mahajan S, Khandelwal N, Agrawal R. Choroidal structural changes in preterm children with and without retinopathy of prematurity. Acta Ophthalmol. 2020;98(5):e611\u20136.","journal-title":"Acta Ophthalmol"}],"container-title":["International Journal of Retina and Vitreous"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40942-023-00520-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40942-023-00520-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40942-023-00520-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T06:07:10Z","timestamp":1704953230000},"score":1,"resource":{"primary":{"URL":"https:\/\/journalretinavitreous.biomedcentral.com\/articles\/10.1186\/s40942-023-00520-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,11]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["520"],"URL":"https:\/\/doi.org\/10.1186\/s40942-023-00520-6","relation":{},"ISSN":["2056-9920"],"issn-type":[{"value":"2056-9920","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,11]]},"assertion":[{"value":"20 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Human subjects were included in this study. The institutional review board of the Tehran University of Medical Science approved the study (). The study was conducted according to the tenets of the Declaration of Helsinki. Any procedure was done after providing parents with informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient's parents (their OCTs were used in Fig.\u00a0) for the publication of any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4"}}